| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | myHome |
| Orderbuch | Realtime Stuttgart | Fundamentalanalyse | Insidertrades | Fonds | Senden | |
| Historisch | Realtime Push | myNews | im Forum | Anleihen | ||
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Deutsche Bank AG | 980,00DKK | +8,05% | 28.05.13 | |||
| Société Générale Group S.A. (SG) | 753,00DKK | -16,98% | 20.03.13 | |||
| Credit Suisse Group | 1.040,00DKK | +14,66% | 12.02.13 | |||
| Goldman Sachs Group Inc. | 1.200,00DKK | +32,30% | 12.02.13 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 920,00DKK | +1,43% | 12.02.13 | |||
| Cheuvreux SA | 925,00DKK | +1,98% | 12.02.13 | |||
| S&P Equity Research | 985,00DKK | +8,60% | 12.02.13 | |||
| Nomura | 1.000,00DKK | +10,25% | 12.02.13 | |||
| Exane-BNP Paribas SA | 895,00DKK | -1,32% | 12.11.12 | |||
| UBS AG | 1.100,00DKK | +21,28% | 07.11.12 | |||
| J.P. Morgan Cazenove | - | - | 07.11.12 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca plc | 1 | 11 | 5 | 30,39 £ | - |
| Bayer | 13 | 13 | 2 | 83,83 € | -0,07% |
| GlaxoSmithKline plc (GSK) | 6 | 7 | 2 | 16,29 £ | - |
| Novartis AG | 10 | 8 | 2 | 69,94 | - |
| Roche Holding AG (Inhaberaktie) | 6 | 5 | 0 | 199,38 | -12,82% |
| Sanofi S.A. | 14 | 7 | 1 | 85,95 € | +5,40% |